Understand what the evidence reveals about using TAVI, a less-invasive valve procedure, in lower risk patients, and what the clinical trial data reveals about outcomes and safety.
Cardiac surgeon Michael J. Reardon, MD, draws on his experience with transcatheter aortic valve implantation clinical trials to explain the data regarding low-risk TAVI patients.
Did you find this article helpful?
Thank you for your feedback.
Subscribe to our Newsletter
Please enter an email
Please enter a valid email
Related Articles